Skip to main content
Equibles
NHI logo

NHI · National Health Investors Inc

Track NHI — free

Use NHI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$70.88 -1.03 (-1.43%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”
View the 10-Q filed Aug 10, 2026
Market Cap
$3.53B
Shares
49.11M

NHI metrics

70 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$70.88
Market cap
$3.53B

Price action

19 metrics
Price change (1W)
-0.9%
Price change (30D)
-4.6%
Price change (3M)
+5.3%
Price change (6M)
-14.5%
Price change (YTD)
-5.8%
Price change (1Y)
-7.1%
Trailing year
Price change (5Y)
+17.2%
52-week high
$91.02
52-week low
$68.32
Change from 52-week high
-21.0%
Change from 52-week low
+5.3%
Annualized volatility
23.6%
Beta
-0.3
RSI (14D)
41.9
Price vs SMA 50
-4.7%
Price vs SMA 200
-8.4%
Avg volume (3M)
564,082
Relative volume
0.5
Average dollar volume
$42.60M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
49.11M

Valuation

12 metrics
P / E (TTM)
20.8
Trailing earnings · reciprocal yield 4.8%
PEG ratio
0.5
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.2×
reciprocal yield 12.2%
P / book
2.2
reciprocal yield 44.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
14.2
reciprocal yield 7.0%
Earnings yield
4.7%

Historical valuation

8 metrics
P / E historical average (3Y)
23.2×
reciprocal yield 4.3%
P / E historical average (5Y)
25.5×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
5.1%
Trailing 12 months
Payout ratio
105.3%
Shareholder yield
5.0%
Dividend / share (TTM)
$3.68
Dividend growth YoY
+2.2%
Dividend growth streak
1
Last ex-dividend
2026-06-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
38.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$166.80M
Trailing 12 months
Diluted EPS (TTM)
$3.46
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.22
Book value per share
$15.91

Growth

11 metrics
Revenue growth YoY
+33.8%
Year over year
Net income growth YoY
+50.5%
Revenue (TTM)
$432.12M
Trailing 12 months
EPS growth YoY
+45.6%
Shares change YoY
+3.6%
Year over year · more shares
Revenue CAGR (3Y)
+10.5%
Revenue CAGR (5Y)
+2.5%
EPS CAGR (3Y)
+26.8%
EPS CAGR (5Y)
-6.1%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
10.6%
Return on assets
5.6%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$30.39M
Total assets
$2.96B
Total debt
$1.13B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$248.68M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$10.10M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
306
13F filer change QoQ
-13
Institutional ownership
78.2%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 5.6 days to cover
Days to cover
5.6d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
$63,767
Insider-sentiment score
76 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 877860 CUSIP 63633D104 13F (30d) 219 filings 212 filers Visit website Investor relations